This book highlights the behavioral and neurobiological issues relevant for drug development, reviews evidence for an innovative approach for drug discovery and presents perspectives on multiple special topics ranging from therapeutic drug use in children, emerging technologies and non-pharmacological approaches to cognitive enhancement.
Emphasizes individual cognitive domains, cutting across disease and disorder, with a perspective on the pharmacology for each Maximizes insights into evolving themes that will bring cognitive research into a new era Gives a broad overview on unique cognitive domains and the potential to treat with drugs the impairments in individual domains rather than in individual neurologic diseases or psychiatric disorders
Kathleen M. Kantak
Alzheimer's Disease Neuroenhancement attention deficit hyperactivity disorder autism bipolar disorder depression psychopharmacology